Wagmann L

References (5)

Title : In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing - Richter_2022_J.Anal.Toxicol__
Author(s) : Richter MJ , Wagmann L , Brandt SD , Meyer MR
Ref : J Anal Toxicol , : , 2022
Abstract :
PubMedSearch : Richter_2022_J.Anal.Toxicol__
PubMedID: 36083120

Title : Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases - Wagmann_2022_Arch.Toxicol__
Author(s) : Wagmann L , Stiller RG , Fischmann S , Westphal F , Meyer MR
Ref : Archives of Toxicology , : , 2022
Abstract :
PubMedSearch : Wagmann_2022_Arch.Toxicol__
PubMedID: 35788413

Title : In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMMSB (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate) and QMiPSB (quinolin-8-yl 4-methyl-3-[(propan-2-yl)sulfamoyl]benzoate) including isozyme mapping and carboxylesterases activity testing - Richter_2022_Drug.Test.Anal__
Author(s) : Richter MJ , Wagmann L , Kavanagh PV , Brandt SD , Meyer MR
Ref : Drug Test Anal , : , 2022
Abstract :
PubMedSearch : Richter_2022_Drug.Test.Anal__
PubMedID: 36239626

Title : In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity - Richter_2021_Metabolites_11_
Author(s) : Richter MJ , Wagmann L , Gampfer TM , Brandt SD , Meyer MR
Ref : Metabolites , 11 : , 2021
Abstract :
PubMedSearch : Richter_2021_Metabolites_11_
PubMedID: 34436449

Title : How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae - Wagmann_2020_Front.Chem_8_539
Author(s) : Wagmann L , Frankenfeld F , Park YM , Herrmann J , Fischmann S , Westphal F , Muller R , Flockerzi V , Meyer MR
Ref : Front Chem , 8 :539 , 2020
Abstract :
PubMedSearch : Wagmann_2020_Front.Chem_8_539
PubMedID: 32766204